Appropriate experimental approaches for predicting abuse potential and addictive qualities in preclinical drug discovery

Bibliography

• Addressing prescription drug abuse in the united states. Current Activities and Future Opportunities. U.S. Department of Health and Human Services; 2013. Available from: http://www.cdc.gov/HomeandRecreationalSafety/pdf/HHS_Prescription_Drug_Abuse_Report_09.2013.pdf
   Google Scholar
• Lintonen T, Konu A, Ronka S, Kotovirta E. Drugs foresight 2020: a delphi expert panel study. Subst Abuse Treat Prev Policy 2014;9(1):18
   PubMedGoogle Scholar
• Guidance for Industry: assessment of abuse potential of drugs. U.S. Department of Health and Human Services; 2010. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM198650.pdf
   Google Scholar
• American Academy of Pain Medicine, American Pain Society and American Society of Addiction Medicine Consensus Document. Definitions related to the use of opioids for the treatment of pain. American Academy of Pain Medicine; 2001. Available from: http://www.naabt.org/documents/aps_consensus_document.pdf
   Google Scholar
• Gerra G, Maremmani I, Capovani B, et al. Long-acting opioid-agonists in the treatment of heroin addiction: why should we call them substitution? Subst Use Misuse 2009;44(5):663-71
   PubMed Web of Science ®Google Scholar
• Mariani JJ, Levin FR. Psychostimulant treatment of cocaine dependence. Psychiatr Clin North Am 2012;35(2):425-39
   PubMed Web of Science ®Google Scholar
• Carpenter MJ, Jardin BF, Burris JL, et al. Clinical strategies to enhance the efficacy of nicotine replacement therapy for smoking cessation: a review of the literature. Drugs 2013;73(5):407-26
   PubMed Web of Science ®Google Scholar
• Kreek MJ. Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine. Ann N Y Acad Sci 2000;909:186-216
   PubMed Web of Science ®Google Scholar
• Koob GF, Weiss F. Pharmacology of drug self-administration. Alcohol 1990;7(3):193-7
   PubMed Web of Science ®Google Scholar
• Horton DB, Potter DM, Mead AN. A translational pharmacology approach to understanding the predictive value of abuse potential assessments. Behav Pharmacol 2013;24(5-6):410-36
   PubMed Web of Science ®Google Scholar
• O’Connor EC, Chapman K, Butler P, Mead AN. The predictive validity of the rat self-administration model for abuse liability. Neurosci Biobehav Rev 2011;35(3):912-38
   PubMed Web of Science ®Google Scholar
• Guidline on the non-clinical investigation of the dependence potential of medicinal products. EMEA; 2006. Report No.: EMEA/CHMP/SWP/94227/2004. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003360.pdf. [Last accessed 26 August 2014]
   Google Scholar
• Beyreuther BK, Freitag J, Heers C, et al. Lacosamide: a review of preclinical properties. CNS Drug Rev 2007;13(1):21-42
   PubMedGoogle Scholar
• Wickenden AD, Yu W, Zou A, et al. Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels. Mol Pharmacol 2000;58(3):591-600
   PubMed Web of Science ®Google Scholar
• Smith PB, Compton DR, Welch SP, et al. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J Pharmacol Exp Ther 1994;270(1):219-27
   PubMed Web of Science ®Google Scholar
• Bardo MT, Bevins RA. Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology (Berl) 2000;153(1):31-43
   PubMed Web of Science ®Google Scholar
• Tzschentke TM. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 1998;56(6):613-72
   PubMed Web of Science ®Google Scholar
• Tzschentke TM. Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 2007;12(3-4):227-462
   PubMed Web of Science ®Google Scholar
• Gauvin DV, Dormer KN, Holloway FA. Pentylenetetrazole can induce a conditioned place preference. Pharmacol Biochem Behav 1991;40(4):987-90
   PubMed Web of Science ®Google Scholar
• Neisewander JL, McDougall SA, Bowling SL, Bardo MT. Conditioned taste aversion and place preference with buspirone and gepirone. Psychopharmacology (Berl) 1990;100(4):485-90
   PubMed Web of Science ®Google Scholar
• Acquas E, Carboni E, Garau L, Di Chiara G. Blockade of acquisition of drug-conditioned place aversion by 5HT3 antagonists. Psychopharmacology (Berl) 1990;100(4):459-63
   PubMed Web of Science ®Google Scholar
• Lew GP, Parker LA. Pentobarbital-induced place aversion. Animal Learning & Behavior 1998;26(2):219-24
   Google Scholar
• Balster RL. Abuse potential of buspirone and related drugs. J Clin Psychopharmacol 1990;10(Suppl 3):31S-7S
   PubMedGoogle Scholar
• Carroll ME, France CP, Meisch RA. Intravenous self-administration of etonitazene, cocaine and phencyclidine in rats during food deprivation and satiation. J Pharmacol Exp Ther 1981;217(2):241-7
   PubMed Web of Science ®Google Scholar
• Collins RJ, Weeks JR, Cooper MM, et al. Prediction of abuse liability of drugs using IV self-administration by rats. Psychopharmacology (Berl) 1984;82(1-2):6-13
   PubMed Web of Science ®Google Scholar
• Bergman J, Spealman RD. Some behavioral effects of histamine H1 antagonists in squirrel monkeys. J Pharmacol Exp Ther 1986;239(1):104-10
   PubMed Web of Science ®Google Scholar
• Katz JL, Goldberg SR. Preclinical assessment of abuse liability of drugs. Agents Actions 1988;23(1-2):18-26
   PubMedGoogle Scholar
• O’Brien CP, Gardner EL. Critical assessment of how to study addiction and its treatment: human and non-human animal models. Pharmacol Ther 2005;108(1):18-58
   PubMed Web of Science ®Google Scholar
• Wilcox KM, Rowlett JK, Paul IA, et al. On the relationship between the dopamine transporter and the reinforcing effects of local anesthetics in rhesus monkeys: practical and theoretical concerns. Psychopharmacology (Berl) 2000;153(1):139-47
   PubMed Web of Science ®Google Scholar
• Johanson CE, Aigner T. Comparison of the reinforcing properties of cocaine and procaine in rhesus monkeys. Pharmacol Biochem Behav 1981;15(1):49-53
   PubMed Web of Science ®Google Scholar
• Mumford GK, Silverman K, Griffiths RR. Reinforcing, subjective, and performance effects of lorazepam and diphenhydramine in humans. Exp Clin Psychopharmacol 1996;4:421-30
   Web of Science ®Google Scholar
• Preston KL, Wolf B, Guarino JJ, Griffiths RR. Subjective and behavioral effects of diphenhydramine, lorazepam and methocarbamol: evaluation of abuse liability. J Pharmacol Exp Ther 1992;262(2):707-20
   PubMed Web of Science ®Google Scholar
• Wolf B, Guarino JJ, Preston KL, Griffiths RR. Abuse liability of diphenhydramine in sedative abusers. NIDA Res Monogr 1989;95:486-7
   PubMedGoogle Scholar
• Ator NA, Griffiths RR. Principles of drug abuse liability assessment in laboratory animals. Drug Alcohol Depend 2003;70(Suppl 3):S55-72
   PubMed Web of Science ®Google Scholar
• Bentzley BS, Fender KM, Aston-Jones G. The behavioral economics of drug self-administration: a review and new analytical approach for within-session procedures. Psychopharmacology (Berl) 2013;226(1):113-25
   PubMed Web of Science ®Google Scholar
• Carter LP, Griffiths RR. Principles of laboratory assessment of drug abuse liability and implications for clinical development. Drug Alcohol Depend 2009;105(Suppl 1)):S14-25
   PubMedGoogle Scholar
• Hursh SR. Behavioral economics of drug self-administration: an introduction. Drug Alcohol Depend 1993;33(2):165-72
   PubMed Web of Science ®Google Scholar
• Johanson CE, Schuster CR. A choice procedure for drug reinforcers: cocaine and methylphenidate in the rhesus monkey. J Pharmacol Exp Ther 1975;193(2):676-88
   PubMed Web of Science ®Google Scholar
• Katz JL. Models of relative reinforcing efficacy of drugs and their predictive utility. Behav Pharmacol 1990;1(4):283-301
   PubMedGoogle Scholar
• Meisch RA. Oral drug self-administration: an overview of laboratory animal studies. Alcohol 2001;24(2):117-28
   PubMed Web of Science ®Google Scholar
• Kirsh K, Peppin J, Coleman J. Characterization of prescription opioid abuse in the United States: focus on route of administration. J Pain Palliat Care Pharmacother 2012;26(4):348-61
   PubMedGoogle Scholar
• Parasrampuria DA, Schoedel KA, Schuller R, et al. Assessment of pharmacokinetics and pharmacodynamic effects related to abuse potential of a unique oral osmotic-controlled extended-release methylphenidate formulation in humans. J Clin Pharmacol 2007;47(12):1476-88
   PubMed Web of Science ®Google Scholar
• Edwards S, Koob GF. Escalation of drug self-administration as a hallmark of persistent addiction liability. Behav Pharmacol 2013;24(5-6):356-62
   PubMed Web of Science ®Google Scholar
• Cohen A, Koob GF, George O. Robust escalation of nicotine intake with extended access to nicotine self-administration and intermittent periods of abstinence. Neuropsychopharmacology 2012;37(9):2153-60
   PubMed Web of Science ®Google Scholar
• Kitamura O, Wee S, Specio SE, et al. Escalation of methamphetamine self-administration in rats: a dose-effect function. Psychopharmacology (Berl) 2006;186(1):48-53
   PubMed Web of Science ®Google Scholar
• Vendruscolo LF, Schlosburg JE, Misra KK, et al. Escalation patterns of varying periods of heroin access. Pharmacol Biochem Behav 2011;98(4):570-4
   PubMed Web of Science ®Google Scholar
• Ahmed SH. Validation crisis in animal models of drug addiction: beyond non-disordered drug use toward drug addiction. Neurosci Biobehav Rev 2010;35(2):172-84
   PubMed Web of Science ®Google Scholar
• Ahmed SH. The science of making drug-addicted animals. Neuroscience 2012;211:107-25
   PubMed Web of Science ®Google Scholar
• Carnicella S, Ron D, Barak S. Intermittent ethanol access schedule in rats as a preclinical model of alcohol abuse. Alcohol 2014;48(3):243-52
   PubMed Web of Science ®Google Scholar
• Samson HH, Czachowski CL. Behavioral measures of alcohol self-administration and intake control: rodent models. Int Rev Neurobiol 2003;54:107-43
   PubMed Web of Science ®Google Scholar
• Hand TH, Franklin KB. The influence of amphetamine on preference for lateral hypothalamic versus prefrontal cortex or ventral tegmental area self-stimulation. Pharmacol Biochem Behav 1983;18(5):695-9
   PubMed Web of Science ®Google Scholar
• Olds J. A preliminary mapping of electrical reinforcing effects in the rat brain. J Comp Physiol Psychol 1956;49(3):281-5
   Google Scholar
• Takigawa M, Mogenson GJ. [Intracranial self-stimulation of the nucleus accumbens of the rat and its associated behavior (author’s transl)]. No To Shinkei 1980;32(3):299-304
   PubMedGoogle Scholar
• Thompson RK, Webster DM. Delayed extinction and drive level effects: septal self-stimulation compared with natural reward. Physiol Behav 1974;12(6):907-12
   PubMed Web of Science ®Google Scholar
• Zacharko RM, Kasian M, Irwin J, et al. Behavioral characterization of intracranial self-stimulation from mesolimbic, mesocortical, nigrostriatal, hypothalamic and extra-hypothalamic sites in the non-inbred CD-1 mouse strain. Behav Brain Res 1990;36(3):251-81
   PubMed Web of Science ®Google Scholar
• Carlezon WA Jr, Chartoff EH. Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat Protoc 2007;2(11):2987-95
   PubMed Web of Science ®Google Scholar
• Wise RA. Addictive drugs and brain stimulation reward. Annu Rev Neurosci 1996;19:319-40
   PubMed Web of Science ®Google Scholar
• Nielsen M, Hansen EH, Gotzsche PC. What is the difference between dependence and withdrawal reactions? a comparison of benzodiazepines and selective serotonin re-uptake inhibitors. Addiction 2012;107(5):900-8
   PubMed Web of Science ®Google Scholar
• West R, Gossop M. Overview: a comparison of withdrawal symptoms from different drug classes. Addiction 1994;89(11):1483-9
   PubMed Web of Science ®Google Scholar
• Satel SL, Price LH, Palumbo JM, et al. Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study. Am J Psychiatry 1991;148(12):1712-16
   PubMed Web of Science ®Google Scholar
• Weddington WW, Brown BS, Haertzen CA, et al. Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. A controlled, residential study. Arch Gen Psychiatry 1990;47(9):861-8
   PubMed Web of Science ®Google Scholar
• Markou A, Koob GF. Postcocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology 1991;4(1):17-26
   PubMed Web of Science ®Google Scholar
• Yang SL, Han JY, Kim YB, et al. Increased non-rapid eye movement sleep by cocaine withdrawal: possible involvement of A2A receptors. Arch Pharm Res 2011;34(2):281-7
   PubMed Web of Science ®Google Scholar
• Martin-Iverson MT, Burger LY. Behavioral sensitization and tolerance to cocaine and the occupation of dopamine receptors by dopamine. Mol Neurobiol 1995;11(1-3):31-46
   PubMed Web of Science ®Google Scholar
• Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 1993;18(3):247-91
   PubMed Web of Science ®Google Scholar
• Robinson TE, Berridge KC. The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 2000;95(Suppl 2):S91-117
   PubMed Web of Science ®Google Scholar
• Robinson TE, Berridge KC. Incentive-sensitization and addiction. Addiction 2001;96(1):103-14
   PubMed Web of Science ®Google Scholar
• Vanderschuren LJ, Pierce RC. Sensitization processes in drug addiction. Curr Top Behav Neurosci 2010;3:179-95
   PubMedGoogle Scholar
• Robinson TE, Berridge KC. Review. the incentive sensitization theory of addiction: some current issues. Philos Trans R Soc Lond B Biol Sci 2008;363(1507):3137-46
   PubMed Web of Science ®Google Scholar
• Morgan D, Roberts DC. Sensitization to the reinforcing effects of cocaine following binge-abstinent self-administration. Neurosci Biobehav Rev 2004;27(8):803-12
   PubMed Web of Science ®Google Scholar
• Morgan D, Smith MA, Roberts DC. Binge self-administration and deprivation produces sensitization to the reinforcing effects of cocaine in rats. Psychopharmacology (Berl) 2005;178(2-3):309-16
   PubMed Web of Science ®Google Scholar
• Mead AN, Crombag HS, Rocha BA. Sensitization of psychomotor stimulation and conditioned reward in mice: differential modulation by contextual learning. Neuropsychopharmacology 2004;29(2):249-58
   PubMed Web of Science ®Google Scholar
• Wise RA. Dopamine and reward: the anhedonia hypothesis 30 years on. Neurotox Res 2008;14(2-3):169-83
   PubMed Web of Science ®Google Scholar
• Wise RA, Rompre PP. Brain dopamine and reward. Annu Rev Psychol 1989;40:191-225
   PubMed Web of Science ®Google Scholar
• Lile JA. Pharmacological determinants of the reinforcing effects of psychostimulants: relation to agonist substitution treatment. Exp Clin Psychopharmacol 2006;14(1):20-33
   PubMed Web of Science ®Google Scholar
• Moser P, Wolinsky T, Castagne V, Duxon M. Current approaches and issues in non-clinical evaluation of abuse and dependence. J Pharmacol Toxicol Methods 2011;63(2):160-7
   PubMed Web of Science ®Google Scholar
• Moser P, Wolinsky T, Duxon M, Porsolt RD. How good are current approaches to nonclinical evaluation of abuse and dependence? J Pharmacol Exp Ther 2011;336(3):588-95
   PubMed Web of Science ®Google Scholar
• ICH Topic M 3 (R2) Non-Clinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals. Note for Guidance on Non-Clinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals (CPMP/ICH/286/95). EMEA; 2008. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002941.pdf
   Google Scholar
• Spragg SDS. Morphine addiction in chimpanzees. Comparative Psychology Monographs 1940;15:1-132
   Google Scholar
• Thompson T, Schuster CR. Morphine Self-Administration, Food-Reinforced, and Avoidance Behaviors in Rhesus Monkeys. Psychopharmacologia 1964;5:87-94
   PubMed Web of Science ®Google Scholar
• Weeks JR. Experimental morphine addiction: method for automatic intravenous injections in unrestrained rats. Science 1962;138(3537):143-4
   PubMed Web of Science ®Google Scholar
• Deiana S, Fattore L, Spano MS, et al. Strain and schedule-dependent differences in the acquisition, maintenance and extinction of intravenous cannabinoid self-administration in rats. Neuropharmacology 2007;52(2):646-54
   PubMed Web of Science ®Google Scholar
• Fattore L, Spano MS, Altea S, et al. Cannabinoid self-administration in rats: sex differences and the influence of ovarian function. Br J Pharmacol 2007;152(5):795-804
   PubMed Web of Science ®Google Scholar
• Rowlett JK. A labor-supply analysis of cocaine self-administration under progressive-ratio schedules: antecedents, methodologies, and perspectives. Psychopharmacology (Berl) 2000;153(1):1-16
   PubMed Web of Science ®Google Scholar
• O’Connor EC, Mead AN. Tramadol acts as a weak reinforcer in the rat self-administration model, consistent with its low abuse liability in humans. Pharmacol Biochem Behav 2010;96(3):279-86
   PubMed Web of Science ®Google Scholar
• Stoops WW. Reinforcing effects of stimulants in humans: sensitivity of progressive-ratio schedules. Exp Clin Psychopharmacol 2008;16(6):503-12
   PubMed Web of Science ®Google Scholar
• de Guglielmo G, Martin-Fardon R, Teshima K, et al. MT-7716, a potent NOP receptor agonist, preferentially reduces ethanol seeking and reinforcement in post-dependent rats. Addiction Biol 2014. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Minhas M, Leri F. The effect of heroin dependence on resumption of heroin self-administration in rats. Drug Alcohol Depend 2014;138:24-31
   PubMed Web of Science ®Google Scholar
• Blier P, Tremblay P. Physiologic mechanisms underlying the antidepressant discontinuation syndrome. J Clin Psychiatry 2006;67(Suppl 4):8-13
   PubMed Web of Science ®Google Scholar